Pyroptosis in inflammatory diseases and cancer.

Rao Z, Zhu Y, Yang P, Chen Z, Xia Y, Qiao C, Liu W, Deng H, Li J, Ning P, Wang Z. · 2022

Read Pyroptosis in inflammatory diseases and cancer. by Rao Z, Zhu Y, Yang P, Chen Z, Xia Y, Qiao C, Liu W, Deng H, Li J, Ning P, Wang Z. (2022) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc9169370.txt.

Introduction

Rao and co-authors review pyroptosis, a fiery form of programmed cell death, in inflammatory diseases and cancer. Pyroptosis is usually set off by inflammasomes and carried out by gasdermin proteins. Cells swell, their membranes break, and their contents spill out. In normal life this helps defend against infection.

Too much pyroptosis, though, can drive lasting inflammation and disease. As a form of immunogenic death, it can also help kill cancer by rousing anti-tumor immunity. The review sums up the signal paths involved and the proof in each disease area. It then covers drugs that block pyroptosis and drugs that trigger it on purpose. Readers get a guide to using a double-edged process as a therapy tool.

Catalog record

CREATORRao Z, Zhu Y, Yang P, Chen Z, Xia Y, Qiao C, Liu W, Deng H, Li J, Ning P, Wang Z.
YEAR2022
COLLECTIONPAPERS
FORMATTXT
FILE SIZE77 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC9169370

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Pyroptosis in inflammatory diseases and cancer By Zhiping Rao, Yutong Zhu, Peng Yang, Zhuang Chen, Yuqiong Xia, Chaoqiang Qiao, Weijing Liu, Hongzhang Deng, Jianxiong Li, Pengbo Ning, Zhongliang Wang Published in: Theranostics DOI: 10.7150/thno.71086 ABSTRACT Pyroptosis is a lytic and inflammatory type of programmed cell death that is usually triggered by inflammasomes and executed by gasdermin proteins. The main characteristics of pyroptosis are cell swelling, membrane perforation, and the release of cell contents. In normal physiology, pyroptosis plays a critical role in host defense against pathogen infection. However, excessive pyroptosis may cause immoderate and continuous inflammatory responses that involves in the occurrence of inflammatory diseases. Attractively, as immunogenic cell death, pyroptosis can serve as a new strategy for cancer elimination by inducing pyroptotic cell death and activating intensely antitumor immunity. To make good use of this double-edged sword, the molecular mechanisms, and therapeutic implications of pyroptosis in related diseases need to be fully elucidated. In this review, we first systematically summarize the signaling pathways of pyroptosis and then present the available evidences indicating the role of pyroptosis in inflammatory diseases and cancer. Based on this, we focus on the recent progress in strategies that inhibit pyroptosis for treatment of inflammatory diseases, and those that induce pyroptosis for cancer therapy. Overall, this should shed light on future directions and provide novel ideas for using pyroptosis as a powerful tool to fight inflammatory diseases and cancer. INTRODUCTION The body maintains a dynamic balance between cell proliferation and cell death, which plays a significant role in the physiopathological processes of multicellular organisms. Cell death is usually categorized as non-programmed cell death and programmed cell death (PCD). Pyroptosis is a type of inflammatory PCD. In 1992, researchers discovered that mouse macrophages infected with Shigella flexneri eventually underwent cell death 1. Later, researchers revealed that inflammatory caspase-1 was activated during Shigella flexneri- or Salmonella-induced cell death 2, 3. So, this type of cell death was originally considered as caspase-dependent apoptosis. However, in 2001, Cookson et al. found that Salmonella-induced cell death displayed completely different characteristics from those of apoptosis. Apoptotic cells have intact membranes accompanied by cell shrinkage, while the membrane integrity of Salmonella-infected macrophages is destroyed by cell swelling 4, 5. Hence, a new term, pyroptosis, was proposed to describe this type of cell death 5, which is characterized by cell membrane pore formation, membrane rupture, cell swelling, and release of cell contents. The factors released during cell death, such as interleukin-1β (IL-1β) and interleukin-18 (IL-18), amplify the inflammatory effects and activate immune responses 6, 7. Although pyroptosis has been proposed for a long time, the underlying mechanism was only uncovered in 2015 upon the discovery and identification of gasdermin D (GSDMD) protein. It was found that cleavage of GSDMD by caspase-1 results in the release of its N-terminal domain (GSDMD-NT), which then forms pores in the cell membrane, thus demonstrating that GSDMD is the central executor of pyroptosis 8. In addition to GSDMD, gasdermin family includes five other members. The human gasdermin family comprises of GSDMA, GSDMB, GSDMC, GSDMD, GSDME/DFNA5, and PVJK/DFNB59. In mice, there are five gasdermin members, including GSDMA, GSDMC, GSDMD, GSDME, and PJVK/DFNB59, but no GSDMB 9, 10. All gasdermins except DFNB59 have two conserved domains, an N-terminal effector domain and a C-terminal inhibitory domain 11. In general, binding of the C-terminal inhibits the pore-forming activity of the N-terminal. In the presence of numerous microbes or other stimulations, gasdermin is cleaved by active caspases or granzymes to liberate the N-terminal domain, which forms large pores in the membrane to release cell contents and execute pyroptosis 12. The Ragulator-Rag-mTORC1 pathway is required for GSDMD oligomerization and pore formation in macrophages 13. Cell-surface protein NINJ1 has an essential role in the induction of plasma membrane rupture, which is responsible for releasing intracellular molecules that propagate the inflammatory response 14. However, the membrane pore can be repaired by endosomal sorting complex required for transport machinery, which initiates by calcium influx through GSDMD pores 15. The membrane repair can allow cells to restrict pyroptosis and provide insight into cellular survival mechanisms during pyroptosis. The occurrence of pyroptosis often crosstalk with a variety of cell death such as apoptosis and necroptosis. Although these different types of cell death induced by distinct mechanisms, they share some similarities and could be activated alone or simultaneously under different conditions. During apoptosis, cleavage of GSDME by caspase-3 mediates progression to pyroptotic cell death 16. Apoptotic caspase-8, generally correlated to apoptosis, was shown to cleave GSDMD and induce pyroptosis 17. In turn, the inflammatory caspase-1 could activate apoptosis in the absence of GSDMD. This caspase-1-induced apoptosis depends on caspase-3 and involves caspase-9 18. Crosstalk between necroptosis and pyroptosis was also discovered recently. Mixed-lineage kinase domain-like protein, the executioner of necroptosis, can also activate NLRP3 inflammasome to promote the maturation of IL-18 and IL-1β 19. However, the maturation and release of cytokines are independent of GSDMD from necroptotic cells 20. Normally, moderate pyroptosis contributes to host defense against pathogen infection, but excessive pyroptosis leads to intemperate inflammatory responses, massive cell death, and serious tissue damage, causing inflammatory or autoimmune diseases. Meanwhile, as a pro-inflammatory type of cell death, pyroptosis paves a new way for cancer elimination by activating antitumor immune response. Here, we first demonstrate different signaling pathways of pyroptosis to gain deep insight into molecular mechanisms. Next, the functions and therapeutic applications of pyroptosis in inflammatory diseases are discussed. Finally, we summarize the roles of pyroptosis in cancer and recent progress in strategies that induce pyroptosis for cancer therapy (Figure 1), which will point out the direction for future research. SIGNALING PATHWAYS OF PYROPTOSIS At present, there are mainly four distinct signaling pathways that have been identified to induce pyroptosis, including canonical and non-canonical inflammasome pathways, apoptotic caspases-mediated pathway, and granzymes-based pathway (Figure 2). In these signaling pathways, gasdermin proteins are the final executioners, which need to be cleaved by upstream caspases or granzymes. Caspases can be categorized into inflammatory and apoptotic caspases based on function 21. Commonly, caspases-1/4/5/11 belong to inflammatory caspases, which play key roles in the innate immune response by inducing pyroptosis to interrupt replication of invading pathogens, and by processing pro-inflammatory cytokines to maturation and release 22. Activation of inflammatory caspase provides the first line of defense against infectious pathogens. Caspase-1 is activated in a multiprotein complex called the inflammasome in the canonical pyroptosis pathway. The inflammatory caspase-4/5/11 do not need such molecular complex for their activation, which were shown to bind lipopolysaccharide (LPS) directly. Apoptotic caspases function predominantly to initiate and execute apoptosis. Recent studies have shown that they can serve as the proteases to cleave gasdermins for pyroptosis induction 16. The details of each signaling pathway of pyroptosis are discussed below. Canonical inflammasome pathway The canonical inflammasome pathway was the first to be discovered. Inflammasomes are multi-protein complexes assembled in response to pathogen-associated molecular patterns or non-pathogen-related damage-associated molecular patterns. Generally, inflammasomes are comprised of intracellular pattern recognition receptors (PRRs), apoptosis-associated speck-like protein containing a caspase-recruitment domain (ASC), and inflammatory caspases 23. The most common PRRs include nucleotide-binding oligomerization domain-like receptors (NLRs, including NLRP1, NLRP3, and NLRC4), absent in melanoma 2 (AIM2), and pyrin 24, 25 (Figure 2A). NLRP1 is composed of an N-terminal

Read the complete text